Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome

Metabolomics

Volumn 11, Issue 6, 2015, Pages 1563-1574

  Ząbek, Adam ^a   Stanimirova, Ivana ^b   Deja, Stanisław ^c   Barg, Wojciech ^d   Kowal, Aneta ^d   Korzeniewska, Anna ^d   Orczyk Pawiłowicz, Magdalena ^d   Baranowski, Daniel ^e   Gdaniec, Zofia ^e   Jankowska, Renata ^d   Młynarz, Piotr ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF SILESIA   (Poland)

^c UNIVERSITY OF OPOLE   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

Chemometrics; Chronic obstructive pulmonary disease (COPD); Discriminant models; NMR spectroscopy; Obstructive sleep apnea syndrome (OSAS)

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BREATH ANALYSIS; CHEMOMETRICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DATA ANALYSIS; FEMALE; HUMAN; MALE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; STATISTICAL ANALYSIS; URINALYSIS;

EID: 84944275817     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-015-0808-5     Document Type: Article

References (37)

1. Andersen, C. M., & Bro, R. (2010). Variable selection in regression-a tutorial. Journal of Chemometrics,24, 728–737.
2. Baraldo, S., Turato, G., & Saetta, M. (2012). Pathophysiology of the small airways in chronic obstructive pulmonary disease. Respiration,84(2), 89–97.
3. Barnes, P. J. (2014). Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clinics in Chest Medicine,35(1), 71–86.
4. Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003). Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. European Respiratory Journal,22(4), 672–688.
5. Basanta, M., Baharudin, I., Docky, R., Douce, D., Morris, M., Singh, D., et al. (2012). Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: A cross-sectional study. Respiratory Research,13, 72–80.
6. 1H NMR metabolomics of exhaled breath condensate. Metabolomics,10, 302–311.
7. Brereton, R. G., & Lloyd, G. R. (2014). Partial least squares discriminant analysis: Taking the magic away. Journal of Chemometrics,28, 213–225.
8. Bro, R., Nielsen, H. J., Savorani, F., Kjeldahl, K., Christensen, I. J., Brünner, N., et al. (2013). Data fusion in metabolomic cancer diagnostics. Metabolomics,9, 3–8.
9. Castaldi, P. J., Cho, M. H., Cohn, M., Langerman, F., Moran, S., Tarragona, N., et al. (2010). The COPD genetic association compendium: A comprehensive online database of COPD genetic associations. Human Molecular Genetics,19(3), 526–534.
10. de Laurentiis, G., Paris, D., Melck, D., Maniscalco, M., Marsico, S., Corso, G., et al. (2008). Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. European Respiratory Journal,32, 1175–1183.
11. de Laurentiis, G., Paris, D., Melck, D., Montuschi, P., Maniscalco, M., Bianco, A., et al. (2013). Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. Journal of Proteome Research,12, 1502–1511.
12. Ergon, R. (2005). PLS post-processing by similarity transformation (PLS + ST): A simple alternative to OPLS. Journal of Chemometr.,19, 1–4.
13. Fens, N., de Nijs, S. B., Peters, S., Dekker, T., Knobel, H. H., Vink, T. J., et al. (2011). Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. European Respiratory Journal,38, 1301–1309.
14. Ferrarini, A., Ruperez, F. J., Erazo, M., Martinez, M. P., Villar-Alvarez, F., Peces-Barba, G., et al. (2013). Electrophoresis,34, 2873–2881.
15. Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated February 2014: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
16. Górska, K., Maskey-Warzechowska, M., & Krenke, R. (2010). Airway inflammation in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine,16(2), 89–96.
17. Gosselin, R., Rodrigue, D., & Duchesne, C. (2010). A bootstrap-VIP approach for selecting wavelength intervals in spectral imaging application. Chemometrics and Intelligent Laboratory Systems,100, 12–21.
18. Hogg, J. C. (2004). Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet,364(9435), 709–721.
19. Jordan, A. S., & White, D. P. (2008). Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respiratory Physiology and Neurobiology,160(1), 1–7.
20. Kohansal, R., Martinez-Camblor, P., Agustí, A., Buist, A. S., Mannino, D. M., & Soriano, J. B. (2009). The natural history of chronic airflow obstruction revisited: An analysis of the Framingham offspring cohort. American Journal of Respiratory and Critical Care Medicine,180(1), 3–10.
21. Kvalheim, O. M. (2010). Interpretation of partial least squares regression models by means of target projection and selectivity ratio plots. Journal of Chemometrics,24, 496–504.
22. Kvalheim, O. M., Arneberg, R., Bleie, O., Rajalahti, T., Smilde, A. K., & Westerhuis, J. (2014). Variable importance in latent variable regression models. Journal of Chemometr.,28, 615–622.
23. Kvalheim, O. M., & Karstang, T. V. (1989). Interpretation of latent-variable regression models. Chemmetrics and Intelligent Laboratory Systems,7, 39–51.
24. Kvalheim, O. M., Rajalahti, T., & Arneberg, R. (2009). X-tended target projection (XTP)—comparison with orthogonal partial least squares (OPLS) and PLS post-preprocessing by similarity transformation (PLS + ST). Journal of Chemometrics,23, 49–55.
25. McClay, J. L., Adkins, D. E., Isern, N. G., O’Connell, T. M., Wooten, J. B., Zedler, B. K., et al. (2010). (1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. Journal of Proteome Research,9, 3083–3090.
26. Paige, M., Burdick, M. D., Xu, K. J., Lee, J. K., & Shim, Y. M. (2011). Pilot analysis of the plasma metabolite profiles associated with emphysematous chronic obstructive pulmonary disease phenotype. Biochemical and Biophysical Research Communications,413, 589–593.
27. Pappas, K., Papaioannou, A. I., Kostikas, K., & Tzanakis, N. (2013). The role of macrophages in obstructive airways disease: Chronic obstructive pulmonary disease and asthma. Cytokine,64(3), 613–625.
28. Park, J. G., Ramar, K., & Olson, E. J. (2011). Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clinic Proceedings,86(6), 549–554.
29. Pillai, S. G., Ge, D., Zhu, G., Kong, X., Shianna, K. V., Need, A. C., et al. (2009). ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics,5(3), e1000421.
30. Rajalahti, T., Arneberg, R., Krosveen, A. C., Berle, M., Myhr, K. M., & Kvalheim, O. M. (2009). Discriminating variable test and selectivity ratio plot: Quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles. Analytical Chemistry,81, 2581–2590.
31. Romero-Corral, A., Caples, S. M., Lopez-Jimenez, F., & Somers, V. K. (2010). Interactions between obesity and obstructive sleep apnea: Implications for treatment. Chest,137(3), 711–719.
32. Stockley, R. A. (2013). Large chronic obstructive pulmonary disease cohorts: Advantages and caution in biomarker discovery/validation. American Journal of Respiratory and Critical Care Medicine,188(12), 1387–1388.
33. Tuomilehto, H., Seppä, J., & Uusitupa, M. (2013). Obesity and obstructive sleep apnea—clinical significance of weight loss. Sleep Medicine Reviews,17(5), 3219.
34. Ubhi, B. K., Cheng, K. K., Dong, J., Janowitz, T., Jodrell, D., Tal-Singer, R., et al. (2012a). Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD. Molecular BioSystems,8, 3125–3133.
35. Ubhi, B. K., Riley, J. H., Shaw, P. A., Lomas, D. A., Tal-Singer, R., MacNee, W., et al. (2012b). Metabolic profiling detects biomarkers of protein degradation in COPD patients. European Respiratory Journal,40, 345–355.
36. Vestbo, J., & Rennard, S. (2010). Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. American Journal of Respiratory and Critical Care Medicine,182(7), 863–864.
37. 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS One,8, e65675.